We focus our development activities on treating diseases where there is a logical match between the biological activity of our boron compounds and the unmet medical needs for a specific disease. We have several clinical programs underway for topical treatment of fungal, inflammatory and bacterial diseases in addition to preclinical programs in the same areas. We have also developed a class of boron-based compounds that show activity in research stage tests in treating systemic bacterial infections. The following chart summarizes our current product candidates.